TVM Capital, CDPQ win CVCA’s 2019 deal of the year awards
TVM Capital Life Science and Caisse de dépôt et placement du Québec (CDPQ) are the 2019 recipients of the Canadian Venture Capital & Private Equity Association's (CVCA) Deal of the Year awards. TVM Capital won in the venture capital category for the 2018 sale of AurKa Pharma, a Montréal-based developer of a cancer treatment for solid tumors, to Eli Lilly. The US$575 million deal generated an IRR of 348 percent and 9.3 x multiple of invested capital. CDPQ won in the private equity category for the 2018 sale of Camso, a Magog, Québec-based maker of off-the-road tires and rubber tracks to Michelin. The transaction was valued at US$1.45 billion.
5 June 2019•5 mins read
